Search

everythinglearnresearchcommunity

for

Search:↓

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Women with PCOS have more severe liver disease.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

Women with PCOS have more Bifidobacterium in their gut compared to those without PCOS.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Diagnosing and treating PCOS in teenagers is difficult, and the focus is on lifestyle changes and medication to improve health and prevent future issues.

Different types of RNAs are found in varying amounts in patients with Polycystic Ovary Syndrome, suggesting they could be important in the disease's development and potentially used as disease markers.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

Some women with PCOS have rare genetic variants linked to the condition.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

PCOS care in Singapore can be bettered by refining referral systems, standardizing diagnosis and treatment, enhancing complication screening, and offering educational resources for clinicians.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Minoxidil can help transgender males grow facial hair before starting testosterone therapy.

Certain gene variations may protect against skin issues and oxidative stress in women with PCOS.

Myo-inositol-based treatments greatly improve pregnancy chances for women with PCOS.

Low vitamin D levels may affect ovulation and progesterone in infertile women.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Different types of female pattern hair loss have unique characteristics and are associated with various health conditions.

Most women lack knowledge about androgens and their excess symptoms.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Postmenopausal hyperandrogenism, a condition with symptoms like increased hair growth and acne, is usually caused by PCOS but can also be due to other factors. It's diagnosed by checking testosterone levels and treated either by removing the adrenal tumor or through antiandrogen therapy.

All women with Polycystic Ovary Syndrome (PCOS) in a study had at least one skin disorder, with the most common being excessive hair growth, acne, dark skin patches, hair loss, and oily skin.

The study suggests using a score of 11 on the mFG scale to diagnose hirsutism in Turkish women, with adjustments for age, skin type, and family history.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

Hirsutism greatly lowers the quality of life for Turkish women.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.